179 related articles for article (PubMed ID: 16174538)
21. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
[TBL] [Abstract][Full Text] [Related]
22. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
[TBL] [Abstract][Full Text] [Related]
23. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
25. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
26. 1% topical cidofovir used as last alternative to treat viral infections.
Briand S; Milpied B; Navas D; Thomare P; Stalder JF
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
[No Abstract] [Full Text] [Related]
27. Current diagnostic and management trends for recurrent respiratory papillomatosis.
Silverman DA; Pitman MJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):532-7. PubMed ID: 15548913
[TBL] [Abstract][Full Text] [Related]
28. Use of cidofovir in recurrent respiratory papillomatosis.
Carifi M
Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2165-6. PubMed ID: 23545883
[No Abstract] [Full Text] [Related]
29. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
30. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
Tasca RA; McCormick M; Clarke RW
Int J Pediatr Otorhinolaryngol; 2006 Jul; 70(7):1183-7. PubMed ID: 16414125
[TBL] [Abstract][Full Text] [Related]
31. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
32. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
Mandell DL; Arjmand EM; Kay DJ; Casselbrant ML; Rosen CA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1319-23. PubMed ID: 15545589
[TBL] [Abstract][Full Text] [Related]
33. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
Pransky SM; Brewster DF; Magit AE; Kearns DB
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
Meacham RK; Thompson JW
Ear Nose Throat J; 2017 Feb; 96(2):69-74. PubMed ID: 28231366
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
[TBL] [Abstract][Full Text] [Related]
36. Cidofovir plasma assays after local injection in respiratory papillomatosis.
Naiman AN; Roger G; Gagnieu MC; Bordenave J; Mathaut S; Ayari S; Nicollas R; Bour JB; Garabedian N; Froehlich P
Laryngoscope; 2004 Jul; 114(7):1151-6. PubMed ID: 15235339
[TBL] [Abstract][Full Text] [Related]
37. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
Carvalho CM; Huot L; Charlois AL; Khalfallah SA; Chapuis F; Froehlich P
Acta Otolaryngol; 2009 Apr; 129(4):462-70. PubMed ID: 19235575
[TBL] [Abstract][Full Text] [Related]
39. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
Calista D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
[TBL] [Abstract][Full Text] [Related]
40. [Cidofovir activity in infantile recurrent respiratory papillomatosis].
Palomar Asenjo V; Palomar García V; Soteras Ollé J; Ruiz Giner A
Acta Otorrinolaringol Esp; 2005 Jan; 56(1):22-4. PubMed ID: 15747720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
